Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1997-1-16
|
| pubmed:abstractText |
The purpose of this clinical study was to analyze a long-term follow-up of all the patients with head and neck cancer in our institution. Between 1973 and 1993, 1,355 consecutive cases of head and neck cancerwere diagnosed, treated and followed up regularly. All were subjected to a multidisciplinary approach, and followed up until death or for 10 years with no event of disease. The local relapse rate was 20% and the node-regional relapse rate 15%. Distant metastases were observed in 6% of the patients mainly arising from the nasopharynx (23%) followed by the hypopharynx (11%). The main organ involved was the lung (50%). Median follow-up of the group was 10 years (range 4 months to 15 years). Cancer cure was observed after 5 years in glottic and supraglottic laryngeal carcinoma, oral and nasopharyngeal cancer and after 2.5 years in patients with cancer of the oropharynx and hypopharynx. The highest cure rate was 80% in the glottis, followed by 70% in the supraglottic area, 45% in the mouth, 30% in the nasopharynx, 25% in the oropharynx, and 20% in the hypopharynx. A second primary tumor was observed in 7% of the patients and a third primary in 0.6% of the patients. Only in 7 patients, the second or third primary was seen after 5 years of follow-up. Curability should be observed after 5 years from definitive therapy of glottic, supraglottic, oral and nasopharyngeal and earlier in oropharyngeal and hypopharyngeal cancer. Further follow-up should be discontinued. Second and third neoplasias are the main problems after 5 years of follow-up but their incidence is low.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0030-2414
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
54
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
38-42
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8978591-Adult,
pubmed-meshheading:8978591-Aged,
pubmed-meshheading:8978591-Aged, 80 and over,
pubmed-meshheading:8978591-Combined Modality Therapy,
pubmed-meshheading:8978591-Disease-Free Survival,
pubmed-meshheading:8978591-Female,
pubmed-meshheading:8978591-Follow-Up Studies,
pubmed-meshheading:8978591-Head and Neck Neoplasms,
pubmed-meshheading:8978591-Humans,
pubmed-meshheading:8978591-Male,
pubmed-meshheading:8978591-Middle Aged,
pubmed-meshheading:8978591-Neoplasm Staging,
pubmed-meshheading:8978591-Survival Analysis,
pubmed-meshheading:8978591-Treatment Outcome
|
| pubmed:articleTitle |
Follow-up study in head and neck cancer: cure rate according to tumor location and stage.
|
| pubmed:affiliation |
Department of Medical Oncology, Hospital Clinic, University of Barcelona, Spain.
|
| pubmed:publicationType |
Journal Article
|